Site Map
Research Article
Chemopreventive Role of Flaxseed Oil against Chemical Induced Skin Cancer in Mammals
Jyoti Sharma, Ritu Singh and Goyal PK*
Radiation & Cancer Biology Laboratory, Department of Zoology, University of Rajasthan, Jaipur, India

Linum usitatissimum, commonly known as flax, is the established medicinal plant which has been used as antiviral, antibacterial, anti-inflammatory, anti-diabetic and cardio-protective agent. The present study was designed to evaluate the anti-tumorogenic potential of flaxseed oil using two stage skin carcinogenesis protocol in Swiss albino mice. A single topical application of 7,12-Dimethylbenz (a) anthracene (DMBA), followed 2 weeks later by the croton oil application thrice in a week till the end of experiment (i.e. 16 weeks), resulted in the 100% tumor incidence. The oral administration of flaxseed oil (100µl/animal/day) at post-initiation (i.e. starting from the day of croton oil application & continued for 16 weeks) and peri-post initiation stage (i.e. 7 days before DMBA application & continued till the end of experiment) resulted in the significant reduction in the tumor incidence, cumulative number of tumors, tumor burden and tumor yield. The average latent period of tumor appearance was prolonged to 11.92 and 12.22 in both these groups in comparison to carcinogen control group (i.e., 7.23). Thus, the results of this experiment demonstrate the potential anti-tumor activity in the flaxseed oil on DMBA/croton oil induced skin carcinogenesis in Swiss albino mice.
Chemical carcinogenesis; Chemoprevention; Flaxseed oil; Tumor burden

Cancer has emerged as a life threatening non-communicable disease and it is characterized by the abnormal proliferation, invasiveness and metastasis of cells. During the last few decades, there has been a sudden increase in the cancer global burden due to the change in life style, environment, genetic variation, virus infection etc. which directly or indirectly responsible for the cancer development [1]. Among all the cancers, skin carcinogenesis are the most prevalent as it represents almost one third of all the newly diagnosed cases. Melanoma and non-melanoma are the two major categories of skin cancer. The two most frequent type of non-melanoma skin cancer comprises Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), which has annual incidences of about 80 and 16% respectively [2].

The two stage skin carcinogenesis model in mouse is a novel tool to study the stages and mechanism of cancer as it displays a pre-neoplastic condition in the form of papillomas that are visible and can be confirmed histopathologically. It involves classical tumor initiator 7, 12-Dimethylbenz (a) anthracene (DMBA) which causes the mutations leading to DNA damage. TPA, the phorbol ester present in Croton oil, acts as the promoter and alters gene expression resulted in hyper proliferation, tissue remodelling and inflammation [3].

Besides the traditional treatment methods like chemotherapy and radiotherapy, there should be an alternative preventive approach to reduce the cancer burden. The administration of herbal and natural products to reverse, inhibit and delay the carcinogenesis is a new area of research known as chemoprevention [4]. It postpones the cancer occurrence in high risk population and simultaneously reduces the side effects of various treatment therapies. Chemopreventive agents modulate different stages of cancer development either by blocking mutagenic carcinogens, scavenging of free radicals or reduction in apoptosis and abnormal cell proliferation [5]. As reported in scientific study cancer cases are directly associated with the nutritional value of diet consumed [6].

Linum usitatissimum, commonly known as flaxseed or linseed belonging to the family linaceae, is grown as important oil seed crop around the globe. Flaxseed oil has various health benefits including antiviral, antibacterial, anti-inflammatory, anti-diabetic and reduction in cardiovascular risks [7,8]. The high a-linoleic acid content, chlorophyll pigments, tocopherol, plastochromanol-8, phenolic acids and flavanoids may play significant role in the pharmacological quality of the oil [9]. The studies on in vivo and in vitro models suggested that flaxseed oil can reduce the effect of breast, prostate, colon and intestinal cancer [10-13].

Looking towards the health benefits of this plant, the present experiment was conducted to evaluate possible anti-cancer activity of flaxseed oil against chemical induced skin carcinogenesis in mammals.
Materials and Methods
The initiator, 7, 12-Dimethylbenz (a) anthracene (DMBA) and the promoter croton oil were procured from Sigma Chemicals Co., St. Louis, USA. DMBA was dissolved at a concentration of 100µg/100µl in acetone. Croton oil was mixed in acetone to give a solution of 1% dilution. Flaxseed oil was procured from Prano flax India Private Ltd.
The protocol of the experiment was approved by Institutional Ethical Committee and the animal care (1678/GO/a/12/CPCSEA) and handling was done according to guidelines set by the World Health Organization, Geneva (Switzerland) and the Indian National Science Academy, New Delhi (India). The present study was conducted on the female Swiss albino mice (7-8 weeks old &weighing 24 ± 2g), selected from a random breed inbreed colony. These animals were housed in polypropylene cages in the animal house under the controlled conditions of temperature (25°C ± 2°C) and light (14 light: 10 dark). The animals were fed a standard mouse feed (procured from Aashirwad Industries, Chandigarh, India) and water was given ad libitum.
Experimental design
Animals for this study were divided into following groups:

Group I: Vehicle treated control (Normal, n=10) Animals of this group received topical application of acetone (100µl/mouse) on the shaven dorsal skin and double distilled water (equivalent to FSO i.e., 100µl/mouse/day) by oral gavage for 16 weeks.

Group II: FSO treated control (Drug control group, n=10) Animals belonging to this group received flaxseed oil (100µl/animal/day) by oral gavage throughout the experimental period i.e., 16 weeks and acted as drug treated control.

Group III: Carcinogen treated (Positive control group, n=10) Mice of this group were treated with single topical application of 100µl DMBA (100µg/100µl acetone) over the shaven area of skin. Two weeks later 100µl croton oil (1% w/v in acetone) was applied topically three times in a week until the end of experimental period.

Group IV: FSO treated (Post-initiation group, n=10) The treatment pattern of DMBA and croton oil was same as group II. This group received FSO (100µl/animal/day) by oral gavage starting from the time of croton oil application until the end of experiment.

Group V: FSO treated (Peri-and post initiation group, n=10) Animals of this group were administered FSO (100µl/animal/day) orally starting from 7 days before DMBA application and continued throughout experimental duration (i.e., 16 weeks).
Induction of tumor
For the induction of skin tumors, dorsal hairs between the cervical and caudal portions of the animals of Group III - V were removed using a surgical clipper, 2 days prior to the initiation of the experiment, and 100µl DMBA (100µg /100µl acetone) was applied. After 14 days, the tumor initiation by DMBA was promoted with the topical application of 100µl croton seed oil (1% v/v in acetone), thrice a week for the next 14 weeks.

During the 16 weeks of experimentation, mice were observed daily and weighed weekly. Tumors appearing on the shaven area of the skin were examined and recorded at weekly intervals in all the above groups. Only those tumors which persisted for two weeks or more, with a diameter greater than 2 mm, have been taken into consideration for final evaluation of the data. Skin tumors, which regressed after one observation, were not accounted.
Optimum dose selection
Different doses (5,10,25,50,100 or 150µl/animal/day) of flaxseed oil was orally administered to the mice for 15 days, and the alterations in morphological parameters like body weight, food & water consumption, general behavior, gait, morbidity, mortality etc. were noted daily till 30 days. The biochemical parameters were evaluated in liver and skin on the 16th and 31st day in the form of Reduced Glutathione (GSH), Lipid Peroxidation (LPO) and total protein. The optimum dose of flaxseed oil was considered in which the highest level of GSH, total proteins and the lowest level of LPO were measured, and the same was used for the further experimentation. The following studies were performed:
Morphological analysis
Cumulative number of papillomas: The total number of papillomas appeared till the termination of the experiment.

Tumor incidence: The number of mice carrying at least one tumor expressed as a percentage incidence.

Tumor yield: The average number of tumors per mouse.

Tumor burden: The average number of tumors per tumor bearing mouse.

Diameter: The diameter of each tumor was measured.

Weight: The weight of each tumor was measured at the termination of experiment.

Body weight: The weight of each mouse was measured weekly.

Average latent period: The time lag between the application of the promoting agent and the appearance of 50% of tumors was determined. The average latent period was calculated by multiplying the number of tumors appearing each week by the time in weeks after the application of the promoting agent and dividing the sum by total number of tumors.

Average latent period =

Where F is the number of tumors appearing each week, X is the numbers of weeks, and n is the total number of tumors.

Inhibition of tumor multiplicity:

Statistical analysis
Data from different experimental groups were analyzed and expressed as mean +SE. The significant levels of difference between carcinogen treated control and FSO treated experimental groups were statistically computed using ?2-test at 5% probability level.
The oral administration of flaxseed oil did not alter the body weight and it was measured near to normal in all groups (Table 1). The animals of Group I and II did not show any tumor development throughout the experimental period. As depicted in (Figure 1), FSO treatment resulted in the significant (P = 0.05) reduction in the cumulative number of tumors i.e., 28 and 22 in the Group IV and V respectively when compared with the carcinogen treated Group III (i.e., 53). The average weight of tumors was reduced from 1.24gm (Group III) to 0.74gm (Group IV) and 0.52gm (Group V) in animals (Table 1). Morphological appearance of tumors in carcinogen treated control group was scaly, larger and darker while in FSO administered groups the tumors were soft, smaller and lighter in color (Figure 2).

Similarly, the tumor yield and tumor burden were also observed to be decreased to 2.8 and 4.0 in post treated group and to 2.2 and 3.5 in peri-post treated group while the same were recorded as much higher i.e., 5.3 and 5.3 in carcinogen control group (Figure 3-4).

A cent percent tumor incidence was observed in the animals after the exposure to carcinogen, however, the tumor appearance with FSO administration was reduced to 70% (7 mice out of 10) and 60% (6 mice out of 10) in Group IV and V respectively.

In carcinogen treated control group, the average latent period was recorded as 7.23 weeks which was found to be considerably prolonged to 11.92 and 12.22 weeks in the FSO administered experimental Group IV and V respectively (Figure 5). The maximum inhibition of tumor multiplicity was recorded as 58.49% in Group V where animals received FSO treatment from one week prior to DMBA application and continued till the end of experiment while the same was noted as 47.17% in the Group IV in which animals received FSO treatment two weeks later DMBA application till the end of experiment.
Human body has the constant exposure of chemical carcinogens in the form of packed food products, beauty products, industrial waste and environmental pollutants. Chemical carcinogens can be categorized into exogenous, which include all physical, chemical and biological agents present outside the body that cause cancer after penetration into the organism, and endogenous carcinogens include metabolic intermediates in the body [14].

In the present study, the carcinogenesis is initiated by the DMBA, the potent indirect chemical carcinogen which is metabolically activated by Cyto. P450 into the 3,4-diol-1,2-epoxide that is capable of binding covalently to DNA and causing gene mutation which ultimately leads to skin carcinogenesis in Swiss albino mice. The main mutation associated with carcinogenesis is in Ras gene that confers selective advance to the epithelial cells. 12-O-Tetradecanoyl Phorbol-13-Acetate (TPA), main constituent of croton oil, is reported to cause activation of protein kinase C which ultimately leads to epidermal proliferation, apoptosis and activation of inflammatory mediators [15].

A wide variety of natural and synthetic compounds has been identified for having chemopreventive potential which can prolong the cancer initiation and progression in various experimental studies [16-20]. Similarly, the observations in the present study indicate that the oral administration of flaxseed oil during post initiation and peri-post initiation stages cause the decrease of 30-40% in the tumor incidences and 47-58% in cumulative number of papilloma of mice.

Chemopreventive agents target the different stages of carcinogenesis as some plant products are noted to be more effective in initiation and others are efficient during promotion stage [21-23]. In the present experiments, the flaxseed oil treatment increased the average latent period in mice when given during promotion stage. The outcome is even better when the treatment is started before the application of initiator. Thus, it is evident that like other plant extracts, the flaxseed oil also exhibits the tumor inhibition during initiation as well as promotion stage.

The medicinal properties of flaxseed oil is assigned due to the presence of high a-linoleic acid content, chlorophyll pigments, ?-tocopherol, plastochromanol-8, phenolic acids and flavonoids [9]. The antioxidative potential of these active constituents reduce the free radicals in the body generated during promotion phase. The results of previous studied clearly indicate that flaxseed oil decrease the oxidative stress by decreasing the lipid per oxidation in biological tissues [24]. The linolenic acid present in flaxseed oil conserves the fatty acid content in membranes and checks the formation of peroxides [25].

As documented earlier in the study carried out by Demark-Wahnefried et al., that the prostate cancer and its associated markers are inhibited by the flaxseed supplemented fat restricted diet [11]. Further, the flaxseed oil is effective against intestinal tumorogenesis and colon cancer by decreasing the expression of COX-1 & COX-2, which are responsible for metabolism of arachidonic acid into prostaglandins, finally leading to inflammation and an increase the apoptosis of tumor cells. Hence it might be possible mechanism of tumor inhibition in the present study after FSO administration [13].

Dietary flaxseed lignans and oil were reported to reduce the growth and metastasis of estrogen receptor negative human breast cancer and they also suppress the metastasis after the surgical excision of primary tumors [26]. Experimental evidences suggested that the oil and mucilage obtained from flaxseed have the preventive potential during the kidney and hepatic injury [27,28]. Similarly, administration of FSO also showed reduction in the length and number of gastric ulcer [29].

The results obtained from the present study are preliminary, and biochemical and histopathological study are under progress to know the chemopreventive potential of flaxseed oil in mice. However, it can be concluded that the synergistic effect of various phytochemicals and omega-3-fatty acid content in the flaxseed oil has the anti-cancer effect to reduce the tumorogenesis in mammals.
Financial assistance received from University Grants Commission (Ref. No. 39/627/2010/SR), New Delhi (India), in the form of a major research project to Prof. P.K. Goyal, is gratefully acknowledged.

  1. Morris CR, Epstein J, Nassere K, Hofer BM, Rico J, et al. (2010) Trends in cancer incidence, mortality, risk factors, and health behaviors in California. Sacramento, CA: California Department of Public Health, Cancer Surveillance Section.
  2. Bradford PT (2009) Skin cancer in skin of color. Dermatol Nurs 21: 170-177, 206.
  3. Singh A, Park H, Kangsamaksin T, Singh A, Readio N, et al. (2012) Keratinocyte stem cells and the targets for non-melanoma skin cancer. Photochem Photobiol 88: 1099-1110.
  4. Mukhtar H (2012) Chemoprevention: making it a success story for controlling human cancer. Cancer Lett 326: 123-127.
  5. Steward WP, Brown K (2013) Cancer chemoprevention: a rapidly evolving field. Br J Cancer 109: 1-7.
  6. Martínez ME, Jacobs ET, Baron JA, Marshall JR, Byers T (2012) Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst 104: 732-739.
  7. Moniem AEA, Dkhil MA, Al-Quraishy S (2010) Protective role of flaxseed oil against lead acetate induced oxidative stress in testes of adult rats. Afri J Biotech 9: 7216-7223.
  8. Chantal MC, Dupasquier, Pierce GN (2007) The cardiovascular benefits of consuming flaxseed: Possible modes of action. International Atherosclerosis Society.
  9. Choo WS, Birch J, Dufour JP (2007) Physicochemical and quality characteristics of cold-pressed flaxseed oils. J Food Comp Anal 20: 202-211.
  10. Wang L, Chen J, Thomson LU (2005) The inhibitory effect of flaxseed on the growth and metastasis of estrogen receptor negative human breast cancer xenograftsis attributed to both its lignan and oil components. Int J Cancer 116: 793-798.
  11. Demark-Wahnefried W, Robertson CN, Walther PJ, Polascik TJ, Paulson DF, et al. (2004) Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 63: 900-904.
  12. William DS, Verghese M, Walker LT, Boateng J, Shacelford LA, et al. (2008) Chemopreventive effects of flaxseed oil or flaxseed meal on azoxymethane induced colon tumors in Fister 344 male rats. Int J Cancer Res 4: 28-40.
  13. Bommareddy A, Zhang X, Schrader D, Kaushik RS, Zeman D, et al. (2009) Effects of dietary flaxseed on intestinal tumorigenesis in Apc (Min) mouse. Nutr Cancer 61: 276-283.
  14. Irigaray P, Belpomme D (2010) Basic properties and molecular mechanisms of exogenous chemical carcinogens. Carcinogenesis 31: 135-148.
  15. Saha D, Hait M (2012) An ontological design: two stage mouse skin carcinogenesis induced by DMBA and promoted by croton oil. Asi J Res Pharmac Sci 2: 01-03.
  16. Sharma R (2012) Cancer Chemoprevention: Prevention is better than Cure. J Cancer Sci Ther 3: 001.
  17. Goyal PK, Verma P, Sharma P, Parmar J, Agarwal A (2010) Evaluation of anti-cancer and anti-oxidative potential of Syzygium Cumini against Benzo[a]Pyrene (BaP) induced gastric carcinogenesis in mice. Asian Pac J Cancer Prev 11: 753-758.
  18. Agrawal A, Verma P, Goyal PK (2010) Chemomodulatory effects of Aegle marmelos against DMBA-induced skin tumorigenesis in Swiss albino mice. Asian Pac J Cancer Prev 11: 1311-1314.
  19. Chatterjee S, Kumar M, Kumar A (2012) Chemomodulatory Effect of Trigonella foenum graecum (L.) Seed Extract on Two Stage Mouse Skin Carcinogenesis. Toxicol Int 19: 287-294.
  20. Parmar J, Sharma P, Goyal PK (2013) Role of Syzygium cumini seed extract in preventing the 7, 12-Dimethylbenz(a)anthracene induced skin carcinogenesis. Res & Rev: J Zoologic Sci 1: 13-25.
  21. Saunders FR, Wallace HM (2010) On the natural chemoprevention of cancer. Plant Physiol Biochem 48: 621-626.
  22. Alias LM, Manoharan S, Vellaichamy L, Balakrishnan S, Ramachandran CR (2009) Protective effect of ferulic acid on 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis in Swiss albino mice. Exp Toxicol Pathol 61: 205-214.
  23. Singh R, Sharma J, Goyal PK (2014) Prophylactic Role of Averrhoa carambola (Star Fruit) Extract against Chemically Induced Hepatocellular Carcinoma in Swiss Albino Mice. Adv Pharmacol Sci 2014: 158936.
  24. Yang W, Fu J, Yu M, Huang Q, Wang D, et al. (2012) Effects of flaxseed oil on anti-oxidative system and membrane deformation of human peripheral blood erythrocytes in high glucose level. Lipids Health Dis 11: 88.
  25. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79: 935-945.
  26. Chen J, Wang L, Thompson LU (2006) Flaxseed and its components reduce metastasis after surgical excision of solid human breast tumor in nude mice. Cancer Lett 234: 168-175.
  27. Abdel-Moneim AE, Dkhil MA, Al-Quraishy S (2011) The potential role of flaxseed oil on lead acetate induced kidney injure in adult male albino rats. Afric J Biotech 10:1436-1451.
  28. Alarifi SA, Aldahmash BA, El-Nagar DM, Dkhil MA (2012) Effect of corn oil, flaxseed oil and black seed oil on lead acetate-induced hepatic tissue damage: A histological study. Journal of Medicinal Plants Research 6: 4128-4134.
  29. Dugani A, Auzzi A, Naas F, Megwez S (2008) Effects of the oil and mucilage from flaxseed (linum usitatissimum) on gastric lesions induced by ethanol in rats. Libyan J Med 3: 166-169.


Figure 1: Variation in appearance of tumors in different groups during chemical induced skin carcinogenesis.

Figure 2: Variation in cumulative no. of tumors in different groups during chemical induced skin carcinogenesis.

Figure 3: Variation in tumor yield in different groups during chemical induced skin carcinogenesis.

Figure 4: Variation in tumor burden in different groups during chemical induced skin carcinogenesis.

Figure 5: Variation in average latent period in different groups during chemical induced skin carcinogenesis.

Group Treatment Body Weight (gm) Tumor Diameter (mm) Tumor
Weight (gm)
Initial Final 2-5mm 6-9mm Total
Vehicle treated control I Acetone 25.56 ± 1.73 32.67 ± 0.45 -- --   -- --
Flaxseed oil treated Control II 100µl/animal/day 27.48 ± 1.87 33.53 ± 1.32 -- --   -- --
Carcinogen treated control III DMBA + Croton oil 25.63 ± 1.95 31.67 ± 1.23 38 15 53 1.24 100
FSO Experimental I IV (DMBA + Croton oil)+FSO 25.66 ± 1.75 34.71 ± 1.12 15 13 28* 0.74* 70
FSO Experimental II V FSO + (DMBA + Croton oil)+FSO 25.84 ± 2.06 35.77 ± 1.37 12 10 22* 0.52* 60
Table 1: Variations in tumor size, weight, incidence and body weight during chemical induced skin carcinogenesis in mice.
Each Value represents mean ± S.E.

Statistical comparison: Control v/s Experimental *p <= 0.05.

Citation: Sharma J, Singh R, Goyal PK (2014) Chemopreventive Role of Flaxseed Oil against Chemical Induced Skin Cancer in Mammals. J Cancer Biol Treat 1: 001.